54 related articles for article (PubMed ID: 10449608)
21. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.
Giorgi Rossi P; Fortunato C; Barbarino P; Boveri S; Caroli S; Del Mistro A; Ferro A; Giammaria C; Manfredi M; Moretto T; Pasquini A; Sideri M; Tufi MC; Cogo C; Altobelli E;
Br J Cancer; 2015 Feb; 112(4):667-75. PubMed ID: 25633037
[TBL] [Abstract][Full Text] [Related]
22. Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.
Oliveira M; Peleteiro B; Lunet N
Eur J Public Health; 2014 Apr; 24(2):253-8. PubMed ID: 23788013
[TBL] [Abstract][Full Text] [Related]
23. Screening for cervical cancer: a systematic review and meta-analysis.
Peirson L; Fitzpatrick-Lewis D; Ciliska D; Warren R
Syst Rev; 2013 May; 2():35. PubMed ID: 23706117
[TBL] [Abstract][Full Text] [Related]
24. Recommendations on screening for cervical cancer.
Dickinson J; Tsakonas E; Conner Gorber S; Lewin G; Shaw E; Singh H; Joffres M; Birtwhistle R; Tonelli M; Mai V; McLachlin M;
CMAJ; 2013 Jan; 185(1):35-45. PubMed ID: 23297138
[No Abstract] [Full Text] [Related]
25. Centralisation of services for gynaecological cancer.
Woo YL; Kyrgiou M; Bryant A; Everett T; Dickinson HO
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD007945. PubMed ID: 22419327
[TBL] [Abstract][Full Text] [Related]
26. [Screening from an epidemiologic perspective].
Becker N
Radiologe; 2008 Jan; 48(1):10, 12-6. PubMed ID: 17960355
[TBL] [Abstract][Full Text] [Related]
27. Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.
Leung GM; Woo PP; McGhee SM; Cheung AN; Fan S; Mang O; Thach TQ; Ngan HY
J Epidemiol Community Health; 2006 Aug; 60(8):712-20. PubMed ID: 16840762
[TBL] [Abstract][Full Text] [Related]
28. Use of private gynaecologist does not relate to better prevention outcomes - an ecological analysis from Finland.
Hemminki E; Sevon T; Tanninen K; Pukkala E; Anttila A
BMC Health Serv Res; 2006 Mar; 6():27. PubMed ID: 16519813
[TBL] [Abstract][Full Text] [Related]
29. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98.
Ronco G; Pilutti S; Patriarca S; Montanari G; Ghiringhello B; Volante R; Giordano L; Zanetti R; Mancini E; Segnan N;
Br J Cancer; 2005 Aug; 93(3):376-8. PubMed ID: 16012518
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer screening.
Wiley DJ; Monk BJ; Masongsong E; Morgan K
Curr Oncol Rep; 2004 Nov; 6(6):497-506. PubMed ID: 15485621
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening programmes and policies in 18 European countries.
Anttila A; Ronco G; Clifford G; Bray F; Hakama M; Arbyn M; Weiderpass E
Br J Cancer; 2004 Aug; 91(5):935-41. PubMed ID: 15280916
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological aspects of cancer screening in Germany.
Becker N
J Cancer Res Clin Oncol; 2003 Dec; 129(12):691-702. PubMed ID: 14557878
[TBL] [Abstract][Full Text] [Related]
33. Organized breast cancer screening programs in Canada.
Miller AB
CMAJ; 2000 Oct; 163(9):1150-1. PubMed ID: 11079061
[No Abstract] [Full Text] [Related]
34. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
35. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
36. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
37. Cost-effective policies for cervical cancer screening. An international review.
Fahs MC; Plichta SB; Mandelblatt JS
Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
[TBL] [Abstract][Full Text] [Related]
38. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
Eltabbakh GH; Eltabbakh GD
J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
[TBL] [Abstract][Full Text] [Related]
39. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
Nieminen P; Kallio M; Anttila A; Hakama M
Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
